My watch list
my.bionity.com  
Login  

Erbitux

News Erbitux

  • New Drug Grips Tumor Cells with Two Arms

    The first patients with advanced tumors have been treated with a novel antibody-based in a clinical trial in the USA. It uses an invention of the Technische Universität Braunschweig: The team of Professor Stefan Dübel, head of the Department of Biotechnology, discovered a human antibody that targets more

  • Merck to Develop Abituzumab in Metastatic Colorectal Cancer with SFJ Pharmaceuticals Group

    Merck announced a development agreement for investigational molecule abituzumab with SFJ Pharmaceuticals Group (SFJ), a US-based company focused on increasing R&D output and productivity through innovative models. “Our collaboration with SFJ illustrates Merck’s increasing focus on strategic partneri more

  • Merck confirms full-year guidance despite headwinds

    Merck reported third-quarter Group sales at the year-earlier level. EBITDA pre exceptionals decreased by -8.3% owing to higher spending on research and development, preparations for the market launches in Healthcare, as well as the business performance of Liquid Crystals. “We generated healthy organ more

All news on erbitux

Publications Erbitux

All publications on erbitux

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE